By Elric Langton | 23 December 2022
Mike and I have a financial interest in SkinBioTherapeutics.
Nervous investors have been sending me queries about the amendment to the operating losses at SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announces that a copy of its unaudited Annual Report and Financial Statements for β¦